Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

KOSS Stock: How Reddit Has Koss Corporation Shares Rocketing Higher

By Robert Lakin, InvestorPlace Contributor

It seems like the WallStreetBets Reddit has discovered Koss stock. The community is fueling a huge surge much like it did in recent days with GameStop.

GME Stock: GameStop’s Dizzying Rally Continues Today

By Robert Lakin, InvestorPlace Contributor

Short-sellers be damned, GameStop continues its feverish climb on Monday. Near $6 a share four months ago, GME stock looks set to open today at more than $93.

TSIA Stock: TS Innovation Shares Skyrocket on Latch SPAC Merger News

By Robert Lakin, InvestorPlace Contributor

TS Innovation Acquisitions is seeing double on Monday morning as news of its merger with property-tech SaaS platform Latch sent TSIA stock up more than 100% in pre-market trading.

BBIG Stock: Why Vinco Ventures Is Soaring 200% Today

By Robert Lakin, InvestorPlace Contributor

BBIG stock is up big on the news that Vinco Ventures is merging with viral content star ZASH. Here's what you should know now.

BTAQ Stock: What to Know About Burgundy Technology and REE Auto SPAC Merger Rumors

By Robert Lakin, InvestorPlace Contributor

BTAQ stock is on the move today as investors speculate on a REE Auto or eToro SPAC merger for Burgundy Technology. Here's what to know.

CLBS Stock: Why Caladrius Biosciences Is Soaring Today

By Robert Lakin, InvestorPlace Contributor

Caladrius Biosciences is focused on treating coronary microvascular dysfunction. The condition is most common among women, especially after menopause.

DARE Stock: Why Daré Bioscience Is on the Move Today

By Robert Lakin, InvestorPlace Contributor

Shares of Daré Bioscience look poised to double between yesterday and today. DARE stock is an investment in women's health niches.

GEVO Stock: Why Renewable Energy Play Gevo Is Climbing Higher Today

By Robert Lakin, InvestorPlace Contributor

Gevo co-founder and Nobel chemistry laureate Frances Arnold was named co-chair of the President’s Council of Advisors on Science and Technology. Renewables are getting more attention as the Biden administration comes into office.

ZOM Stock: Why Zomedica Shares Are on the Move Again Today

By Robert Lakin, InvestorPlace Contributor

Zomedica shares are surging after the company updated investors on a warrant-redemption cash influx and news that its end-of-March product rollout is on track. Pet-related stocks are hot and ZOM may be on the verge of a significant breakout.

Cannabis Stocks: 5 Reasons HEXO, MJ and APHA Stock Are on the Move Today

By Robert Lakin, InvestorPlace Contributor

Cannabis stocks are active again on Thursday morning just a week before pot-friendly Democrats take power in Washington. HEXO, Aphria and a marijuana ETF are just a few of what's popping in pre-market.

Load More